Drugs that contain Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate

1. List of Moviprep drug patents

MOVIPREP's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7169381 SALIX PHARMS Colon cleansing compositions and methods
Sep, 2024

(1 year, 3 months from now)

US7658914 SALIX PHARMS Colon cleansing compositions
Sep, 2024

(1 year, 3 months from now)

Do you want to check out MOVIPREP patents from before 2022?

Market Authorisation Date: 02 August, 2006

Treatment: NA

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of MOVIPREP before it's patent expiration?
More Information on Dosage

MOVIPREP family patents

8

United States

4

Germany

3

Spain

3

Denmark

3

Russia

3

Japan

3

Portugal

3

Slovenia

3

Australia

3

European Union

2

Hong Kong

2

Poland

2

China

2

Canada

2

Cyprus

2

United Kingdom

1

Austria

1

Turkey

1

Mexico

1

South Africa

1

Lithuania

1

Hungary

2. List of Plenvu drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10792306 SALIX Colonoscopy—preparation
Mar, 2032

(8 years from now)

US11529368 SALIX Colonoscopy—preparation
Mar, 2032

(8 years from now)

US10780112 SALIX Colonoscopy-preparation
Mar, 2032

(8 years from now)

US10646512 SALIX Colonoscopy - preparation
Mar, 2032

(8 years from now)

US9592252 SALIX Colonoscopy—preparation
Aug, 2032

(9 years from now)

US10918723 SALIX Colon cleansing compositions and methods of use
Sep, 2033

(10 years from now)

US9707297 SALIX Compositions
Sep, 2033

(10 years from now)

US10016504 SALIX Compositions
Sep, 2033

(10 years from now)

US8999313 SALIX Compositions
Sep, 2033

(10 years from now)

US9326969 SALIX Compositions
Sep, 2033

(10 years from now)

Do you want to check out PLENVU patents from before 2022?

Market Authorisation Date: 04 May, 2018

Treatment: For cleansing of the colon in preparation for colonoscopy in adults

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of PLENVU before it's patent expiration?
More Information on Dosage

PLENVU family patents

17

United States

8

European Union

7

Korea, Republic of

6

Spain

6

China

6

Singapore

6

Japan

6

Israel

6

Australia

6

South Africa

5

Denmark

5

Portugal

5

United Kingdom

4

Poland

4

Canada

EA

4

EA

3

Malaysia

3

RS

3

Brazil

3

Ukraine

3

New Zealand

3

Croatia

3

Taiwan

3

Slovenia

3

Mexico

3

Lithuania

3

Hungary

2

Hong Kong

2

Argentina

2

ME

1

Ireland

1

India

1

San Marino

1

Cyprus

1

Netherlands

1

Finland

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in